Beacon Pointe Advisors’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Beacon Pointe Advisors’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-82	Closed	-$11.1K	–	1198
2022 Q4	$11.1K	Sell	82 -1	-1%	-$200	﹤0.01%	1057
2022 Q3	$17K	Hold	83	–	–	﹤0.01%	990
2022 Q2	$28K	Hold	83	–	–	﹤0.01%	1031
2022 Q1	$49K	Buy	+83	New	+$49.3K	﹤0.01%	1174
2021 Q4	–	Sell	-18	Closed	-$22K	–	1014
2021 Q3	$22K	Buy	18 +4	+29%	+$7.76K	﹤0.01%	893
2021 Q2	$44K	Hold	14	–	–	﹤0.01%	823
2021 Q1	$83K	Buy	14 +1	+8%	+$7.25K	0.01%	521
2020 Q4	$72K	Sell	13 -2	-13%	-$12.6K	﹤0.01%	498
2020 Q3	$90K	Sell	15 -12	-44%	-$70K	0.01%	392
2020 Q2	$166K	Buy	+27	New	+$183K	0.02%	383

Other funds holding YARW

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Beacon Pointe Advisors's YARW Position: Q1 2023 in Review

Beacon Pointe Advisors sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2023, closing a stake of 82 shares — an estimated $11.1K sold.

Beacon Pointe Advisors first reported a position in YARW in Q2 2020 and held it in 10 quarters. The position peaked at $166K in Q2 2020. 21 funds tracked by Wall St. Rank hold YARW as of Q1 2023.

Beacon Pointe Advisors reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Beacon Pointe Advisors sold 82 Yarrow Bioscience, Inc. Common Stock shares in Q1 2023, an estimated $11.1K.
Beacon Pointe Advisors first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Beacon Pointe Advisors's Yarrow Bioscience, Inc. Common Stock position peaked at $166K in Q2 2020.
21 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2023.

Based on Beacon Pointe Advisors's 13F filing for Q1 2023, filed 12 May 2023.